Category: Include on Menu
-

Nektar Therapeutics shares jump after positive atopic dermatitis trial results
Nektar Therapeutics (NASDAQ:NKTR) stock rose 7% Thursday following the announcement of encouraging outcomes from its REZOLVE-AD Phase 2b study of rezpegaldesleukin for patients with moderate-to-severe atopic dermatitis. The company reported that rezpegaldesleukin met the primary endpoint of mean improvement in Eczema Area and Severity Index (EASI) at week 16 compared with baseline across all treatment…
-

Cardlytics shares surge after bullish mention from Citron Research
Cardlytics (NASDAQ:CDLX) saw its stock jump 30% following a positive report from Citron Research, which labeled the company as the “next fallen angel poised for significant gains.” Citron highlighted Cardlytics’ strong partnerships with major banks and financial institutions—including American Express, Chase, Bank of America, Wells Fargo, Citibank, and Lloyds—as a major advantage. The research firm…
-

Jumia Technologies shares rise on Google’s major investment in African digital infrastructure
Jumia Technologies AG (NYSE:JMIA) saw its stock climb 2% after Google announced substantial investments aimed at expanding internet connectivity across Africa, a key region for Jumia’s e-commerce operations. Google revealed that it has surpassed its 2021 commitment of $1 billion to enhance African internet infrastructure ahead of schedule, planning to establish four strategic subsea cable…
-

Laser Photonics shares surge after successful live drone neutralization
Laser Photonics Corporation (NASDAQ:LASE) jumped 32.9% Thursday following news that its Laser Shield Anti-Drone (LSAD) System successfully neutralized a live drone during field testing. The industrial laser systems company, in collaboration with Fonon Technologies, reported that the LSAD system effectively disabled an active drone in short-range trials. This milestone represents a major step toward commercial…
-

Beam Global shares jump after new battery tech patent approval
Beam Global (NASDAQ:BEEM) surged 12.5% after announcing it received a patent for its advanced battery thermal management system. The U.S. Patent Office granted Patent No. US 12,422,195 to Beam for its Phase Change Composite (PCC™) material, designed specifically for lithium-ion batteries. Unlike conventional solutions, Beam’s Smart PCC™ acts as a thermal switch—insulating batteries in cold…
-

Synopsys shares climb on chip industry news
Synopsys Inc (NASDAQ:SNPS) rose 7% Thursday morning, a move that analysts are attributing to Intel’s (NASDAQ:INTC) newly announced partnership with Nvidia (NASDAQ:NVDA) rather than any direct company-specific news. The collaboration between Intel and Nvidia, which involves developing multiple generations of custom data center and PC products using NVIDIA NVLink to connect architectures, has sparked optimism…
-

AquaBounty shares surge after meeting Nasdaq listing requirements
AquaBounty Technologies Inc (NASDAQ:AQB) saw its stock jump 33% in premarket trading Thursday after the biotechnology company confirmed it has regained compliance with Nasdaq’s minimum bid price rule. The company received formal confirmation from Nasdaq’s Listing Qualifications Department on September 15, 2025, verifying that AquaBounty now satisfies the minimum bid price requirement under Nasdaq Listing…
-

Brunswick shares rise after announcing fiberglass boat production consolidation
Brunswick Corporation (NYSE:BC) saw its stock gain 2.2% in premarket trading Thursday following the company’s announcement of a global consolidation of its fiberglass boat manufacturing operations aimed at cutting fixed costs and boosting efficiency. The company plans to close its Reynosa, Mexico plant, which produces primarily small, value-oriented fiberglass boats, shifting production to U.S. facilities…
-

Intellia shares rise after completing enrollment in pivotal Phase 3 HAE study
Intellia Therapeutics Inc. (NASDAQ:NTLA) saw its stock climb 5.5% in premarket trading Thursday after the company announced the completion of enrollment in its Phase 3 HAELO trial of lonvoguran ziclumeran for hereditary angioedema (HAE). The Cambridge, Massachusetts-based biotech completed enrollment in just nine months, with nearly 50% of participants coming from the U.S. Intellia aims…
-

DeFi Development shares rise after unveiling Treasury Accelerator initiative
DeFi Development Corp. (NASDAQ:DFDV) saw its stock gain 1.7% in premarket trading Thursday following the launch of its Treasury Accelerator program, designed to deploy the company’s balance sheet directly into Digital Asset Treasuries (DATs). The Nasdaq-listed firm, which positions itself as the first public company with a treasury strategy centered on Solana (COIN:SOLUSD) accumulation, plans…